Clinical Trials Directory

Trials / Conditions / Kidney Tumor

Kidney Tumor

14 registered clinical trials studyying Kidney Tumor — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium
NCT07480044
Zhejiang UniversityN/A
RecruitingCRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
NCT07053462
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLCPhase 1 / Phase 2
RecruitingVirtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy
NCT06056505
University of LeipzigN/A
RecruitingEngineering Immune Organoids to Study Pediatric Cancer
NCT05890781
Gustave Roussy, Cancer Campus, Grand ParisN/A
RecruitingRenal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
NCT05728957
Loyola University—
RecruitingDecision Aid (DA) for Renal Patients
NCT05387863
NYU Langone HealthN/A
CompletedMixed Reality Technology in Laparoscopic Partial Nephrectomy
NCT05015179
St. Petersburg State Pavlov Medical UniversityN/A
CompletedGRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses
NCT03819569
UNC Lineberger Comprehensive Cancer CenterN/A
CompletedUltrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
NCT01908166
Stanford UniversityN/A
UnknownIReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.
NCT01967407
University of MagdeburgPhase 1 / Phase 2
CompletedSildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
NCT01950923
Wake Forest University Health SciencesPhase 1
WithdrawnImaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
NCT01688414
Stanford UniversityN/A
TerminatedA Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Par
NCT00960063
Merck Sharp & Dohme LLCPhase 1
CompletedLiposomal Doxorubicin in Treating Children With Refractory Solid Tumors
NCT00019630
National Cancer Institute (NCI)Phase 1